Eli Lilly issues Q4 2024 revenue guidance below consensus
by
Contributor since / Followers
Contributor since / Followers
1 day ago
jetcityimage/iStock Editorial via Getty Images
Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B.
The consensus revenue estimate stands at $13.95B.
“While the U.S. incretin market grew 45% compared to the same quarter last year, our previous guidance